Canopy’s June quarter didn’t give us any indication that they’re ready to create cannabis at margin or make a jump to a reasonable rate of growth.
Featuring @iandawkins on CDN Cannabis banking, gnashing of teeth among the $N army, and confusion over the $TGOD spinout from @mmjinvesting and @Bartonius
@BettingBruiser’s report on $ACB’s portfolio is a great read if you can get through it. We broke out a summary for a pre-earnings call amuse-bouche.
$ACB’s made a $175M all-stock bid for private Whistler Medical after unloading some $TGOD. $CRON may have something to say about this before it’s over.